Company Filing History:
Years Active: 2010
Title: Innovations by Yohannes Teffera
Introduction
Yohannes Teffera is an accomplished inventor based in Topsfield, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical use. His work focuses on creating effective treatments for diseases mediated by vascular endothelial growth factor (VEGF).
Latest Patents
Yohannes Teffera holds a patent for "Benzomorpholine derivatives and methods of use." This patent includes selected benzomorpholine compounds, such as 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-(5-methyl-3-isoxazolyl)-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide. These compounds are effective for the prophylaxis and treatment of diseases, including those related to VEGF. The invention encompasses novel compounds, analogs, prodrugs, and pharmaceutically acceptable salts, along with pharmaceutical compositions and methods for treating conditions such as cancer. Additionally, the patent details processes for making these compounds and the intermediates useful in such processes.
Career Highlights
Yohannes Teffera is currently employed at Amgen Inc., a leading biotechnology company. His role involves research and development of innovative pharmaceutical solutions. His expertise in the field has led to advancements in treatments that address critical health issues.
Collaborations
Yohannes has collaborated with notable colleagues, including Jean-Christophe P Harmange and Matthew W Martin. These partnerships have contributed to the successful development of his patented inventions.
Conclusion
Yohannes Teffera's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions through patents and collaborations continue to pave the way for advancements in medical treatments.